Diclofenac 50 mg + Paracetamol 325 mg + Trypsin-Chymotrypsin 50,000 AU Film-Coated Tablet

Diclofenac 50 mg + Paracetamol 325 mg + Trypsin-Chymotrypsin 50,000 AU Film-Coated Tablet is a film-coated tablet formulated with Diclofenac 50 mg + Paracetamol 325 mg + Trypsin-Chymotrypsin 50,000 AU. The active ingredient profile is Diclofenac; Paracetamol; Trypsin-Chymotrypsin, placing the product in the nsaid + analgesic + proteolytic enzyme combination category. The formulation combines analgesic/anti-inflammatory ingredients with proteolytic enzyme components commonly used as adjuncts in clinician-managed inflammatory or soft-tissue conditions. The film coating provides a finished oral solid-dosage presentation and may support handling, stability and product acceptability. For website cataloguing, composition, strength, dosage form and release/coating characteristics should be displayed prominently and consistently. The description should remain factual and should not include unapproved cure, superiority, guaranteed-result or broad therapeutic claims. Clinical selection should depend on diagnosis, patient-specific factors, contraindications, concomitant medicines and the prescriber’s judgement. Prescription status, precautions, interactions, adverse effects and dosing must be checked against the current approved product label before publication. Manufacturer, licence, storage, shelf-life, pack configuration and market-specific regulatory details should be added only from verified product documentation.